Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Capital Expenditures (2023 - 2025)

Historic Capital Expenditures for Fractyl Health (GUTS) over the last 3 years, with Q3 2025 value amounting to $8000.0.

  • Fractyl Health's Capital Expenditures fell 9624.41% to $8000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $787000.0, marking a year-over-year decrease of 5281.77%. This contributed to the annual value of $1.8 million for FY2024, which is 39164.35% up from last year.
  • Fractyl Health's Capital Expenditures amounted to $8000.0 in Q3 2025, which was down 9624.41% from $98000.0 recorded in Q2 2025.
  • Over the past 5 years, Fractyl Health's Capital Expenditures peaked at $1.1 million during Q1 2024, and registered a low of $8000.0 during Q3 2025.
  • Over the past 3 years, Fractyl Health's median Capital Expenditures value was $148000.0 (recorded in 2023), while the average stood at $243454.5.
  • Its Capital Expenditures has fluctuated over the past 5 years, first surged by 519500.0% in 2024, then crashed by 9624.41% in 2025.
  • Quarter analysis of 3 years shows Fractyl Health's Capital Expenditures stood at $136000.0 in 2023, then surged by 71.32% to $233000.0 in 2024, then tumbled by 96.57% to $8000.0 in 2025.
  • Its Capital Expenditures stands at $8000.0 for Q3 2025, versus $98000.0 for Q2 2025 and $448000.0 for Q1 2025.